Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Medications Archives
Print | Email | Share | Comments (0)

New Drug For Type 2: Precose Gets FDA OK

Nov 1, 1995

Precose, a new oral drug from Bayer, was recently granted market clearance by the FDA for the treatment of type 2 diabetes.

Precose, also called acarbose, works differently than current drugs. By slowing the digestion of carbohydrates in the small intestine, Precose decreases the rise in blood sugar that typically occurs after eating. As a result, the drug allows the body's own insulin to better regulate blood glucose levels.

"When diet and exercise fail, Precose can be an ideal treatment for patients with type 2 diabetes," says Harold Lebovitz, MD, Professor of Medicine at SUNY Downstate Medical Center, Brooklyn, N.Y. "Precose significantly reduces after-meal glucose levels. In addition, unlike sulfonylurea drugs, Precose does not cause hypoglycemia, hyperinsu-linemia, or weight gain."

According to Bayer, side effects of the drug "tend to be gastrointestinal in nature, such as flatulence, abdominal distention, and diarrhea due to fermentation of undigested carbohydrates. However, these symptoms have been moderate and generally diminish over time."

Says Frank Vinicor, MD, MPH, President of the ADA, "Type 2 diabetes is a serious, complex disease best managed through an individualized treatment plan. Acarbose offers physicians and the diabetes healthcare team a new tool in determining the best course of treatment for people with type 2 diabetes and for helping them achieve glycemic control."

Precose has been available for over four years in Europe under the brand name Glucobay.

Mean Change in HbA1c in Fixed Dose Monotherapy Studies

Dose of Precose}Change in HbA1c

(three times per day)

}25 mg }decreased 0.44

}50 mg }decreased 0.77

}100 mg }decreased 0.74

Doses in excess of 100 mg three times per day are not recommended


Categories: A1c Test, Blood Glucose, Blood Sugar, Diabetes, Government & Policy, Insulin, Low Blood Sugar, Medications, Type 2 Issues, Type 2 Medications



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Nov 1, 1995

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.